高级检索
当前位置: 首页 > 详情页

Effect of male body mass index on clinical outcomes following assisted reproductive technology: a meta-analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Tongji Univ, Sch Med, Dept Urol, Tongji Hosp, 389 Xincun Rd, Shanghai 200065, Peoples R China [2]Tongji Univ, Sch Med, Dept Reprod Ctr, Tongji Hosp, Shanghai 200092, Peoples R China [3]Tongji Univ, Sch Med, Dept Surg, Tongji Hosp, Shanghai 200092, Peoples R China [4]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Urol, Shanghai 200030, Peoples R China
出处:
ISSN:

关键词: assisted reproductive technology body mass index clinical pregnancy rate invitro fertilisation intracytoplasmic sperm injection

摘要:
Overweight and obese males might exhibit a great risk of infertility. However, according to the current studies, the association between elevated male body mass index (BMI) and the clinical adverse results after assisted reproductive technology (ART) remains controversial. Hence, we conducted a meta-analysis to evaluate the effects of raised male BMI on clinical outcomes following ART. PubMed, EMBASE and three Chinese databases were used to identify relevant studies. The primary outcome was clinical pregnancy rate. Secondary outcomes included live birth rate and sperm parameters. A total of 5262 male participants from 10 cohort studies were subjected to meta-analysis. Results indicated that overweight or obese had no significant impact on clinical pregnancy rate [invitro fertilisation (IVF): odds ratio (OR), 0.73; 95% confidence interval (CI), 0.39-1.39; intracytoplasmic sperm injection (ICSI): OR, 1.03; 95% CI, 0.92-1.15], live birth rate (IVF: OR, 0.91; 95% CI, 0.78-1.06; ICSI: OR, 1.00; 95% CI, 0.50-1.99) and sperm concentration (SMD, -0.28; 95% CI, -0.65 to 0.08) compared with normal weight following IVF/ICSI treatments. Exclusion of any single study and almost all the sensitivity analyses showed that our results were reliable. At present, the role of male BMI in the process of ART is only partly understood and should be further investigated.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 男科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 男科学
JCR分区:
出版当年[2014]版:
Q3 ANDROLOGY
最新[2023]版:
Q3 ANDROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Tongji Univ, Sch Med, Dept Urol, Tongji Hosp, 389 Xincun Rd, Shanghai 200065, Peoples R China [2]Tongji Univ, Sch Med, Dept Reprod Ctr, Tongji Hosp, Shanghai 200092, Peoples R China [*1]Department of Urology, Tongji Hospital, Tongji University School of Medicine, 389 Xincun Road, Shanghai 200065, China
共同第一作者:
通讯作者:
通讯机构: [1]Tongji Univ, Sch Med, Dept Urol, Tongji Hosp, 389 Xincun Rd, Shanghai 200065, Peoples R China [2]Tongji Univ, Sch Med, Dept Reprod Ctr, Tongji Hosp, Shanghai 200092, Peoples R China [*1]Department of Urology, Tongji Hospital, Tongji University School of Medicine, 389 Xincun Road, Shanghai 200065, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)